Skip Navigation


Annals of Oncology Advance Access originally published online on March 5, 2008
Annals of Oncology 2008 19(4):822-824; doi:10.1093/annonc/mdn043
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/4/822    most recent
mdn043v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bahri, S.
Right arrow Articles by Su, M.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bahri, S.
Right arrow Articles by Su, M.-Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

letters to the editor

Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer?

The first 10% of the full text of this article appears below.

The lymph node status is regarded as one of the most important prognostic factors for the overall and disease-free survival of patients with breast cancer. While morphological features and contrast enhancement kinetics of breast cancer shown on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) have been correlated with tumor histological type, grade, and biomarkers [1–4], there were only few studies reporting the association of lesion features such as rim enhancement and kinetic feature (early maximal enhancement and washout) with node status and showed controversial results [5–7]. In this study, we investigated the . . . [Full Text of this Article]

funding

S. Bahri1, J.-H. Chen1,2,*, H. J. Yu1, A. Kuzucan1, O. Nalcioglu1 and M.-Y. Su1

1 Tu and Yuan Center for Functional Onco-Imaging, University of California, Irvine, CA, USA
2 Department of Radiology, China Medical University Hospital, Taichung, Taiwan

* (E-mail: jeonhc@uci.edu)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
N. Tuncbilek, M. Kaplan, S. Altaner, I. H. Atakan, N. Sut, O. Inci, and M. K. Demir
Value of Dynamic Contrast-Enhanced MRI and Correlation with Tumor Angiogenesis in Bladder Cancer
Am. J. Roentgenol., April 1, 2009; 192(4): 949 - 955.
[Abstract] [Full Text] [PDF]